Incannex Healthcare (IXHL) Treasury Shares (2024 - 2025)

Incannex Healthcare (IXHL) posted quarterly Treasury Shares of $670469.0 for Q1 2025, little changed on a QoQ basis from $670469.0 in Q4 2024.

Incannex Healthcare (IXHL) Treasury Shares (2024 - 2025) Analysis & Trends

Incannex Healthcare (IXHL) has reported Treasury Shares for 2 consecutive years, with $670469.0 the latest figure, recorded in Q1 2025.

Quarterly Treasury Shares changed N/A year-over-year to $670469.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $670469.0 (changed N/A YoY) and the FY2024 annual result came in at $651939.0, changed N/A from the prior year.
Treasury Shares held at $670469.0 in Q1 2025 per IXHL's latest filing, from $670469.0 in the prior quarter.
Over the last five years, Treasury Shares for IXHL reached as high as $670469.0 in Q3 2024 and fell as low as $651939.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	62.52 Mn
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	107.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	11.29 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	313.27 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	5.44 Bn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	1.01 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Incannex Healthcare	3.63 Mn	3.63 Mn	-	-

Download Data